To whom should violations regarding the LearningRx disclosure document be reported?
Learningrx Franchise · 2025 FDDAnswer from 2025 FDD Document
If LearningRx Franchise Corporation does not deliver this disclosure document on time or if it contains a false or misleading statement, or a material omission, a violation of federal law and state law may have occurred and should be reported to the Federal Trade Commission, Washington, DC 20580, and the appropriate state agency identified on EXHIBIT D.
Source: Item 22 — CONTRACTS (FDD page 54)
What This Means (2025 FDD)
According to LearningRx's 2025 Franchise Disclosure Document, if the document is not delivered on time, contains false or misleading statements, or has material omissions, a violation of federal and state law may have occurred. In such cases, the document states that these violations should be reported to the Federal Trade Commission (FTC) in Washington, DC 20580, and to the appropriate state agency. Exhibit D of the FDD identifies the relevant state agency to contact.
It is standard practice in the franchise industry for the FDD to contain information on how to report potential violations. This ensures that prospective franchisees are aware of their rights and have avenues for recourse if they believe they have been provided with inaccurate or incomplete information. The FTC is the primary federal agency responsible for enforcing franchise laws and regulations, while state agencies oversee franchise registration and compliance within their respective jurisdictions.
For a prospective LearningRx franchisee, this information is crucial. It provides a clear path to take if they suspect any discrepancies or misrepresentations in the disclosure document. By reporting violations to both the FTC and the relevant state agency, franchisees can help ensure that LearningRx complies with franchise laws and that their rights are protected. Franchisees should carefully review Exhibit D to identify the appropriate state agency for their location.